Diana Moore replaces Conrad Mir at Advaxis
This article was originally published in Scrip
Executive Summary
Conrad Mir, executive director of business development at Advaxis, a biotechnology company developing immunotherapies for cancer and infectious diseases, has left the company to pursue other interests, and has been replaced by Diana Moore who has been appointed director of investor relations and business development. Ms Moore has been at Advaxis for two years in various roles.